Bio-Rad Laboratories has announced the launch of the SEQuoia Express Stranded RNA Library Prep Kit, providing an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive transcriptome profiling.
PerkinElmer has announced the launch of the BioQule NGS System, an automated benchtop solution for next-generation sequencing (NGS) library preparation of up to eight samples.
EKF Diagnostics has launched its new EKF Link digital connectivity solution for the secure management of point-of-care (POC) analysers and associated data on one centralised platform.
Cirdan’s key partner in Australia, Australian Clinical Labs, has improved the stability and functionality of its pathology workflows through the successful deployment of Cirdan’s Laboratory Information System (LIS), ULTRA version 4.6.
The British In Vitro Diagnostics Association (BIVDA) has welcomed the In Vitro Diagnostic Medical Devices Regulation (IVDR) and urges continued work to deploy the new regulatory system.
Xyall, a global innovator in molecular pathology, has attracted a Series B investment of six million Euros to accelerate commercialisation of its Tissector High Throughput and Tissector Table Top systems.
From cancer to birth defects to infectious disease, modern gene and bioanalysis is the key to personalised medicine.
One in eight people who were hospitalised with COVID-19 between May 2020 and March 2021 were later diagnosed with myocarditis, or heart inflammation, according to major new research into the clinical long-term effects of COVID-19.
Indica Labs, a provider of computational pathology software and services, has announced a CE-IVD mark for HALO Prostate AI, a screening tool designed to assist pathologists in identifying and grading prostate cancer in needle biopsies.
A research team at the University of Bayreuth has been taking advantage of the most popular pipette controller, INTEGRA’s PIPETBOY acu 2, for the preparation of buffers, media and samples in its cell culture workflows.
Pneumagen, a clinical-stage biotechnology company developing Neumifil, a broad-spectrum antiviral intranasal drug, has reported positive topline data from a phase 1 study designed to evaluate safety and tolerability in healthy volunteers.
Diagnostica Medica and Proteomedix, the Swiss cancer diagnostics company, have announced that Proclarix , a new blood test for the management of prostate cancer patients, has been introduced in the routine of the laboratory.
Maternal obesity impairs heart health and function of the fetus according to a new study in mice.